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Abstract. The highly toxic nature of tabun has been known for many years, but there are still serious limi-
tations to antidotal therapy. In this study, we used rats as an experimental model to evaluate the efficiency 
of bispyridinium para-oxime K203 as therapy against tabun poisoning as well as to examine if induction 
of oxidative stress is linked to organophosphate toxicity. K203 showed high potency in counteracting 
tabun poisoning. Either alone or in combination with atropine, this oxime significantly increased cholines-
terase activity at 0.5 and 1 h compared to untreated rats poisoned with tabun. Simultaneous measurements 
of markers of oxidative stress (lipid peroxidation and superoxide dismutase) showed that tabun poisoning, 
but also therapy (oxime alone or oxime plus atropine) applied immediately after tabun poisoning, could 
generate free radical species that may cause oxidative stress in rats. (doi: 10.5562/cca1811) 
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INTRODUCTION 
Organophosphorus (OP) compounds such as nerve 
agents (tabun, soman, sarin and VX) and pesticides 
[paraoxon, chlorpyrifos, and tetraethyl pyrophosphate 
(TEPP)] constitute an extremely toxic group of com-
pounds.1 Nerve agents like tabun are still a potential 
threat for both military and civilian populations. The 
toxic symptomatology of OP is caused primarily by 
irreversible inhibition of cholinesterases, in particular 
acetylcholinesterase (AChE). Inhibition by OP com-
pounds is manifested through conjugation of a phospho-
rous group from OP to the catalytic serine residue at the 
active site of the enzyme.2 AChE is a vitally important 
enzyme that hydrolyzes the neurotransmitter acetylcho-
line (ACh), which is involved in the numerous choliner-
gic pathways in both the central and peripheral nervous 
system. Consequently, inhibition of AChE results in 
severe cholinergic toxic signs caused by increased con-
centration of ACh at cholinergic nerve–nerve and nerve–
muscle synapses.3 A combination of anticholinergics 
(atropine) and AChE reactivators (oximes) is currently 
used for the treatment of OP intoxications.4 Atropine 
blocks muscarinic acetylcholine-receptors and prevents 
them from further stimulation by ACh. In this way, atro-
pine relieves the symptoms of OP poisoning, but it does 
not threat the poisoning itself. AChE reactivators are 
mono- or bis-quaternary pyridinium salts bearing in their 
molecule a functional oxime group able to reactivate 
inhibited AChE by displacing the phosphoryl residue 
from the active site and restoring the enzyme activity. 
Pralidoxime (2-PAM), TMB-4, obidoxime and HI-6 are 
the most commonly used oximes for the treatment of OP 
exposure. However, reactivation by these oximes is not 
possible in all cases of OP poisoning, especially in the 
case of the nerve agent tabun. Namely, tabun-
phosphorylated AChE is resistant to reactivation due to 
low electrophilicity of the phosphoramidate conjugated 
to the AChE active site.5 Furthermore, Musilek et al.6 
reported that steric hindrance induced by tabun-inhibited 
AChE led to partial closing of the enzyme’s active site, 
so that only few bispyridinum oximes could enter the 
active site to reactivate tabun-inhibited AChE. The most 
promising of the standard oximes, HI-6, cannot reacti-
vate tabun-inhibited enzyme, though it exerts a signifi-
cant protection via different mechanisms.7 Oxime TMB-
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4 effectively reactivates tabun-inhibited AChE, and it 
also reduces or alleviates the toxic effects of tabun, 
showing beneficial effects in the treatment of tabun-
poisoned animals.8−9 But it is the most toxic oxime of the 
four mentioned oximes.10 Therefore, there is still a need 
to develop not only the most effective, but also the least 
toxic organophosphate antidote. 
Recent in vitro and in vivo studies draw attention 
to oxime [(E)-1-(4-carbamoylpyridinium)-4-(4-hydro-
xyiminomethylpyridinium)-but-2-ene dibromide] (K203) 
as a very potent reactivator of tabun-inhibited 
AChE.11−14 In this study, we used rats as the experi-
mental model to broaden our knowledge about the anti-
dotal potency of K203 as well as to evaluate the exist-
ence of oxidative stress and its involvement in OP tox-
icity. Namely, it is nowadays known that additional 
noncholinergic mechanisms contribute to OP toxicity.15 
Some of these mechanisms include excessive generation 
of free radicals.16 If the free radical production over-
whelms the endogenous antioxidant levels, free radical 
activity can lead to cell damage, known as oxidative 
stress. Thus, rat plasma samples were analyzed for total 
cholinesterase (ChE) activity and levels of oxidative 
stress markers (concentration of thiobarbituric reactive 
substances, TBARS as a measure of lipid peroxidation 
and activity of the antioxidant enzyme superoxide dis-
mutase, SOD) after exposure to tabun, oxime, atropine 




The structure of the studied oxime K203 and tabun is 
given in Figure 1. K203 [(E)-1-(4-carbamoylpyridini-
um)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene 
dibromide] was prepared as described earlier17 at the 
Faculty of Military Health Sciences, Hradec Králové, 
Czech Republic. It was kept at room temperature and 
was dissolved in distilled water or atropine immediately 
before use. Doses used in the experiments were 8.41 
and 42.05 mg kg−1 body weight, corresponding to 5 and 
25 % of its LD50 (LD50 = 168.2 mg kg
−1), respectively.12 
Atropine sulphate (Kemika, Zagreb, Croatia) was dis-
solved in distilled water (5.0 mg mL−1) and applied at a 
dose of 10 mg kg−1 body weight. Tabun [ethyl N,N-
dimethylphosphoroamidocyanidate] was purchased 
from the NC Laboratory, Spiez, Switzerland. Stock 
solution of 5000 μg mL−1 tabun was prepared in isopro-
pyl alcohol. Further dilutions were made in saline short-
ly before use. Rats were poisoned with a sublethal dose 
(75 % LD50; LD50 = 317.5 μg kg
−1 body weight) of 
tabun. Other chemicals and reagents used were pur-
chased form Sigma Chemical Co., St. Louis, MO, USA, 
unless specified otherwise. 
Animals 
Adult male Wistar rats were obtained from the Institute 
for Medical Research and Occupational Health, Zagreb, 
Croatia, and were selected for weight (240−280 g). The 
animals were kept in Macrolone cages under controlled 
conditions (room temperature 21 °C, light and dark 
cycles exchanging every 12 h), received a standard diet 
for laboratory rodents (Sljeme, Zagreb, Croatia) and had 
free access to water. The rats (N=128) were randomly 
divided into groups of four animals each. This study 
was performed with the approval of the Ethical Com-
mittee of the Institute for Medical Research and Occu-
pational Health, Zagreb, Croatia. 
 
Treatment 
For the purpose of biochemical experiments, rats re-
ceived a subcutaneous (s.c.) sublethal dose (75 % LD50) 
of tabun. The therapeutic efficacy of oxime K203 was 
tested as follows: a) K203 alone (5 or 25 % LD50) one 
minute after tabun poisoning, b) K203 (5 or 25 % LD50) 
plus atropine one minute after tabun poisoning. Other 
three groups of animals were treated with oxime only (5 
or 25 % LD50) or just atropine. Oxime and atropine were 
administered intraperitoneally (i.p.). Control rats re-
ceived i.p. 2 mL kg−1 of saline (i.p.). All animals were 
humanely euthanized 0.5, 1, 6 or 24 h after the treat-
ment. Blood samples were obtained directly from the 
heart. Plasma was separated by centrifugation and 
stored at −20 °C until further processing. 
 
Cholinesterase Activity 
The catalytic activity of cholinesterases in plasma was 
determined spectrophotometrically using the method of 
Ellman et al.18 which is based on the use of 5,5´-
dithiobis (2-nitrobenzoic acid) (DTNB) as a thiol rea-
gent in the presence of acetylthiocholine iodide (ATCh) 
as substrate. The measured activity represented total 




Figure 1. Structure of the tested oxime and tabun. 
S. Berend et al., Efficacy of Oxime K203 and Oxidative Stress in Tabun Poisoned Rats 195 
Croat. Chem. Acta 85 (2012) 193. 
Lipid Peroxidation 
Concentration of thiobarbituric reactive substances 
(TBARS), as a measure of lipid peroxidation, was de-
termined using a modification of the method of Drury et 
al.19 Concentration of TBARS was calculated using 
standard curves of increasing 1,1,3,3-tetra-
methoxypropane concentrations and was expressed as 
µmol L−1. 
 
Superoxide Dismutase Activity 
Plasma total SOD activity was measured 
spectrophotometrically according to Flohé and Ötting.20 
The reduction rate of cytochrome c by superoxide radi-
cals was monitored at 550 nm utilizing the xantine-
xantine oxidase system as the source for O2
.−. SOD 
competed for superoxide and decreased the reduction 
rate of cytochrome c. One unit of SOD was defined as 
the amount of enzyme that inhibits the rate of cyto-
chrome c reduction by 50 %. Enzyme activity was ex-




Determination of protein concentration was carried out 
according to the method of Bradford21 using bovine 
serum albumin as standard. 
 
Statistical Analysis 
Data were expressed as median & interquartile range. 
Statistical significance was determined using the Mann-
Whitney test and differences were considered signifi-
cant when P < 0.05. 
 
RESULTS AND DISCUSSION 
Organophosphorus compounds poisoning is a major 
public health concern. Indeed, self-poisoning by OP 
pesticides is responsible for some 200,000 deaths a 
year in the world22 and some potent chemical warfare 
agents are today considered as potential terrorist 
agents. Although prevention and therapy of poisoning 
with OP compounds has been a subject of many stud-
ies, therapy with atropine and oximes still leaves much 
to be desired. Pyridinium oximes have probably been 
known for more than half a century, but there is no 
single compound that can counteract the toxic poten-
tial of each OP. This was the reason for synthesizing a 
new group of bispyridinium oximes as potential anti-
dotes against OP poisoning. In the Czech Republic, 
considerable efforts have been invested into the devel-
opment of new reactivators to be used in cases of 
tabun poisoning. The best recommended oxime of the 
third generation of the so called K-oximes for tabun-
inhibited AChE seems to be oxime K203.23 In our 
recently published study, we obtained a high percent-
age of reactivation of tabun-inhibited human erythro-
cyte AChE in a short time with micromolar concentra-
tions of K203.12 Furthermore, K203 in combination 
with atropine given one minute after tabun poisoning 
ensured survival of all mice at an 8.0 LD50 dose of 
tabun.12 In the last three years, similar results were 
also published by other researchers.6,11,13,14 
The primary objective of this study was to de-
termine the ability of K203 to reactivate plasma cho-
linesterase in tabun-poisoned rats. We characterized 
poisoning through the intensity of toxic signs and 
through the level of ChE inhibition. Plasma samples 
were measured for total cholinesterase activities. 
Namely, rodent plasma contains higher amount of 
butyrylcholinesterase than acetylcholinesterase.24 OP 
compounds inhibit both enzymes although sometimes 
at different rates.1 Administration of a single sublethal 
dose of tabun induced twitch potentiation, 
fasciculations and muscular weakness. Signs of toxici-
ty reached maximum 15 min to 1 h after tabun admin-
istration. Changes in cholinesterase activity are shown 
in Figure 2. Tabun produced maximum ChE inhibition 
at 1 h after exposure, while after 24 h plasma activities 
in poisoned rats increased. Administration of atropine 
or oxime alone did not affect the ChE activity in rat 
plasma. What is even more important is that oxime 
K203 did not modify enzyme activity even at a dose of 
25 % of its LD50 although one could expect so because 
it is known that oximes are reversible inhibitors of 
ChE.4 As regards therapeutic efficacy, K203 either 
alone or in combination with atropine significantly 
increased ChE activity at 0.5 and 1 h, compared to rats 
poisoned with tabun. There were no considerable dif-
ferences in responses between the applied doses of 
K203. Judging by the followed time course of changes 
for ChE activity, the pharmacological effect of K203 
alone seems to be almost equal to the effect of the 
K203 and atropine combination. Although the thera-
peutic effects of pyridinium oximes can be greatly 
improved if given with atropine, our results confirmed 
the hypothesis that oxime reactivation is the only 
treatment modality for OP exposure when recovery of 
the original condition of an active enzyme molecule is 
desired. Mechanistic studies of oxime action have 
shown that oximes as reversible ligands may bind 
either at the catalytic site or at the allosteric site, or at 
both sites of the enzyme, thus explaining the mecha-
nism of reactivation or protection afforded by oxime 
administration.25 Taking in account the underlying 
mechanisms, it becomes clear that stereochemical 
arrangements of oximes play an important role in their 
therapeutic efficacy. The structure of oxime K203 
containing the functional oxime group at position four 
at one pyridinium ring and carbamoyl group at the 
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other pyridinium ring with (E)-but-2-ene linker sug-
gests K203 as a potential candidate for treatment of 
tabun intoxication. According to QSAR studies with a 
set of 11 oximes, Bhattacharjee et al.26 reported that in 
K203 the distance between the bisquaternary nitrogen 
atoms (N+−N+), increased hydrophilicity, lower surface 
area, and lower nucleophilic power of the oxime oxygen 
together provide the necessary stereoelectronic attrib-
utes that enable K203 to be a better and less toxic 
reactivator for tabun-inhibited AChE. According to our 
previously published results, K203 showed moderate 
toxicity in mice and rats.12 Since most OP nerve agents 
are volatile and hydrophobic, they cross the blood-brain 
barrier and become sequestered in the brain and periph-
ery, from which they slowly relieve. Hence the OP 
inactivation in plasma must be efficient. At this point, 
we demonstrated that administration of oxime K203 one 
minute after tabun poisoning seems to be effective in 
restoring the activity of cholinesterases in rat plasma. 
Even more, when applied at a dose 5 % of its LD50, 
which is considered to be a medical dose,27 this oxime 
was also capable to display excellent levels of reactiva-
tion. 
 
Since other mechanisms, notably oxidative stress, 
have been proposed for the toxicity of OP in animals 
and humans, another objective of this study was to esti-
mate the levels of oxidative stress markers. The lipo-
philic nature of OP facilitates their interaction with the 
cell membrane and leads to perturbations of the phos-
pholipid bilayer structure.28 It was therefore decided to 
determine the concentration of thiobarbituric reactive 
substances (TBARS) as a measure of lipid peroxidation 
(Figure 3), and to see whether there is any difference in 
this parameter upon tabun poisoning and therapies ad-
ministrated to rats. Single application of compounds, 
even exposure to tabun, did not increase plasma TBARS 
concentrations when compared to control. On the other 
hand, the same range of values or higher than control 
was obtained in plasma samples of rats that received 
therapy one minute after tabun poisoning. In most cases 
in plasma of animals that received therapy TBARS 
concentration was significantly higher than the TBARS 
concentration in plasma of tabun poisoned rats. In ani-
mals sacrified 30 min after the treatment there were no 
differences between therapy containing K203 alone and 
therapy combined of K203 and atropine. Also, in that 
 
 
Figure 2. Changes in cholinesterase activity in plasma of rats following the treatment with tabun (75 % LD50), oxime K203 (5 or
25 % LD50), atropine (10 mg kg
−1) and their combinations. Significantly increased values (P < 0.05) are: (a) compared to the
control; (b) compared to tabun-poisoned rats; (c) compared to rats given 5 % LD50 K203 plus atropine as therapy; (d) compared to
rats given 25 % LD50 K203 as therapy. Asterisk denotes data from Ref. 12. 
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time period no significant dose dependence considering 
oxime K203 was observed. During longer time periods 
difference in TBARS concentration depending on the 
dose of oxime was noticed, and generally the highest 
increase of TBARS concentration was observed in 
plasma of rats that received therapy combined of oxime 
and atropine immediately after tabun poisoning. Unfor-
tunately, without a detailed insight into metabolizing 
processes we cannot claim that there is a negative syn-
ergism of tabun, oxime and atropine combination that 
could cause elevation of free radicals and 
consenquently lipid peroxidation. To the best of our 
knowledge, there are no published data on the relation-
ship of this parameter with atropine and oxime treat-
ment in the acute OP poisoning. There is however a 
study reported by Abu-Qare and Abou-Donia29 that 
demonstrated potential of prophylactic drug 
pyridostigmine bromide and nerve agent sarin to in-
crease the urinary biomarkers of oxidative stress after 
combined exposure in rats. Nevertheless, our study has 
demonstrated that acute exposure to sublethal dose of 
tabun did not increase concentration of lipid peroxida-
tion products. Although many studies have revealed 
histopatological and biochemical changes in target 
tissues through OP induced oxidative stress,30 there are 
a few reports showing no oxidative stress upon expo-
sure to OP in in vivo models. For example, Hazarika et 
al.31 found that anilofos cannot cause lipid peroxidation 
in cell membranes of liver and brain in exposed rats. 
Silva et al.32 demonstrated that no change is observed 
in the biochemical parameters related to oxidative 
stress in malathion exposed mice. Important fact for 
discussion is that much of the data regarding involve-
ment of oxidative stress in OP toxicity were gathered 
from the studies with OP pesticides.30 Since several 
phenomena appear to differentiate nerve agent expo-
sure from exposure to pesticides, extrapolation to pre-
dictions of effects from nerve agents may be subject to 
risk. The sparse available data suggest that large toxic 
doses of OP nerve agents cause acute necrotic neuronal 
cell death, whereas sublethal doses produce apoptotic 
neuronal cell death and involve oxidative stress.33 
 
Figure 3. Changes in the TBARS concentration in plasma of rats following the treatment with tabun (75 % LD50), oxime K203 (5
or 25 % LD50), atropine (10 mg kg
−1) and their combinations. Significantly different values (P < 0.05) are: (a) compared to the
control; (b) compared to tabun-poisoned rats; (c) compared to rats administrated atropine alone; (d) compared to rats given K203
alone as therapy. 
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In view of the possible oxidative stress involved in 
OP poisoning, rat plasma samples were also analyzed 
for the activity of the antioxidant enzyme superoxide 
dismutase. SOD is considered to be one of the first lines 
of defence against deleterious effects of oxyradicals in 
the cell by catalyzing the dismutation of superoxide 
radicals.31 As seen from Figure 4, SOD activities in 
plasma samples of control rats progressively decreased 
up to 24 h. The same trend was noticed in plasma of 
tabun poisoned rats but during all time periods tabun 
poisoning resulted with significantly higher SOD activi-
ties than control. Interestingly, administration of atro-
pine or oxime (5 or 25 % LD50) alone caused an oppo-
site response of plasma SOD activity. During the first 
hour SOD activities in rats that received either atropine 
or oxime were significantly lower than in controls. An 
increase was noticed at 6 and 24 h following atropine or 
oxime administration and almost the same values of 
SOD activities as in the control groups were achieved. 
The same response was observed in rats that received 
therapies applied one minute after tabun poisoning. Yet 
it is important to emphasize that high SOD activities 
detected in plasma samples of rats poisoned with a 
sublethal dose of tabun significantly differ from all 
other treatments. Thus, we could say that tabun poison-
ing induced generation of free radicals and led to a 
marked increase in enzymatic antioxidant activity. It 
seems that this early response of SOD has an impact on 
other processes related to oxidative stress, i.e. by neu-
tralizing superoxide radicals it prevents lipid peroxida-
tion. Accumulation of lipid peroxidation products is 
believed to be a major contributor to the loss of cell 
function under oxidative stress conditions.30 An increase 
in enzymatic and nonenzymatic antioxidants of defence 
mechanisms might be an indicator of the decrease in 
TBARS level. According to our results it is possible that 
the induction of SOD activity prevented lipid peroxida-
tion after tabun poisoning. However, the studied effect 
of acute exposure to a sublethal dose of tabun on oxida-
tive stress induction is probably not the best approach, 
presumably because a 24 h period and a single dose of 
tabun are inadequate conditions to delineate the role of 
oxidative stress in the toxicity of OP. 
 
CONCLUSIONS 
Together with published data on K203 efficacy, our 
results indicate the high potency of this oxime in coun-
 
Figure 4. Changes in superoxide dismutase (SOD) activity in plasma of rats following the treatment with tabun (75 % LD50),
oxime K203 (5 or 25 % LD50), atropine (10 mg kg
−1) and their combinations. Significantly increased values (P < 0.05) are: (a)
compared to the control; (b) compared to tabun-poisoned rats. 
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teracting tabun poisoning. Judging by the followed time 
course of changes for ChE activity in rat plasma, it 
seems that the therapeutic effect of this oxime is indeed 
related to the reactivation of tabun-phoshorylated en-
zyme. 
Based on simultaneous measurements of TBARS 
and SOD, we can conclude that tabun poisoning, but 
also application of therapy (oxime alone or oxime plus 
atropine) immediately after tabun poisoning, could 
generate free radical species that may cause oxidative 
stress in rats. Finally we suggest that the in vivo effects 
of these componds should be investigated further to 
better understand underlying mechanisms that could 
lead to development of better antidotes. 
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